Skip to content

5Y Capital is a Chinese venture capital firm focused on investing in technology and innovative companies.

Last updated October 9, 2026

AI crawler reads

3requests

1companies
  • Anthropic3
Profile
2
Controversies
0
JSON · MD
0
First read
Nov 4, 2026
Latest read
Nov 4, 2026

From this site's server log

Overview

5Y Capital is a Chinese venture capital firm that invests primarily in technology, internet and other innovative companies. The organization previously operated under names associated with Morningside-related investment activities and later adopted the 5Y Capital brand. Its work generally includes equity investments in early- and growth-stage companies, together with strategic and operating support for portfolio companies. Publicly verifiable information available for this entry is insufficient to state its exact founding year, management team, fund size, investment record or current organizational structure with confidence.

History

5Y Capital is an investment-firm brand operating in China's venture capital market. Publicly available information indicates that the brand has an organizational and business-history connection with Morningside-related investment activities in China, and that it later operated under the name 5Y Capital. Its investment focus has generally included internet, technology and other innovation-oriented sectors. Because sufficiently reliable public sources are not available for this entry, no specific founding year, rebranding date, fundraising amount, representative exits or historical management appointments are provided.

Products and positioning

A venture capital firm focused on technology and innovative companies

  • Investment services

    Venture capital investment

    The firm's core activity is providing equity investment to innovative startups, with a general focus on technology, internet and related new-economy sectors. Specific fund stages, ticket sizes and investment terms vary by project and are not further specified here because sufficiently reliable public information is unavailable.

  • Post-investment services

    Portfolio-company support

    In addition to capital, venture firms may provide portfolio companies with strategic, talent, business-network or follow-on-financing support. The form and extent of such support may differ by investment, and available material is insufficient to define a standardized service list for 5Y Capital.

Recent events

  • Unconfirmed

    Reported

    汇翮智能 Completes Over US$200 Million in Funding[1]

    汇翮智能 said its team has completed over US$200 million in cumulative funding, with participation from IDG Capital, Tencent, 5Y Capital, Ant Group, Sequoia China, Transsion Holdings, 同歌创投 and 上海交大菡源资产.

  • Reported

    Leman Biotech completes nearly RMB 100 million angel funding[2]

    Leman Biotech announced on January 18 that it had completed an angel funding round of nearly RMB 100 million, led by Tiantu Capital, with 5Y Capital and XtalPi also investing. The funding is intended to advance preclinical research and drug-candidate development, among other stated uses.

  • Reported

    ReviR Therapeutics completes approximately $20 million Pre-A financing[3]

    ReviR Therapeutics completed a Pre-A financing round of approximately $20 million. The company said the funds would advance its voyageR discovery platform and support expansion of its research team.

  • Reported

    Unknownjun completes Series B funding[4]

    Unknownjun announced that it had completed its Series B financing, totaling nearly US$100 million.

  • Reported

    Huobanyun completes $40 million Series B+ funding[5]

    Huobanyun completed a $40 million Series B+ financing, with new and existing investors participating. The company said the funding would support product upgrades and customer-centered process optimization.

  • Unconfirmed

    UMU completes C3 funding round[6]

    UMU completed a C3 funding round worth several hundred million yuan, led by Huaxing New Economy Fund with participation from 5Y Capital.

  • Reported

    Axbio completes a new funding round[7]

    Axbio announced that it had completed a new funding round worth tens of millions of US dollars. The report says the funds would be used for further AXP-series product research and development, GMP factory construction, and commercialization.

  • Reported

    Xiaopeng HT Aero completes Series A funding[8]

    Xiaopeng HT Aero announced that it had completed a Series A financing of more than US$500 million, led by IDG Capital, 5Y Capital, and XPeng Motors.

  • Reported

    Xingyao Technology completes a strategic funding round[9]

    Xingyao Technology announced that it had completed a new funding round led by the Shanghai Artificial Intelligence Industry Investment Fund, with existing investors also participating. The company said the proceeds would support drug-development pipelines, team expansion, and research capabilities.

  • Reported

    Zhuiyi Technology announces strategic investment[10]

    Zhuiyi Technology announced that it had received several hundred million yuan in strategic investment from China Internet Investment Fund and China Mobile Innovation Industry Fund; existing investors including Wuyuan Capital and Gaorong Capital also added investment.

Read more(14)

Sources16 sources

Cite this profile: Cite the canonical profile. /brand-wiki/5y-capital · Editorial policy · How profiles are compiled